Amesite Inc. (NASDAQ:AMST – Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totaling 50,029 shares, an increase of 96.4% from the September 15th total of 25,472 shares. Based on an average trading volume of 198,545 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.2% of the company’s stock are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Amesite in a research note on Friday, August 21st. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Amesite currently has an average rating of “Sell”.
Read Our Latest Stock Analysis on AMST
Amesite Stock Performance
Amesite (NASDAQ:AMST – Get Free Report) last issued its quarterly earnings results on Wednesday, September 23rd. The company reported ($0.18) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.96) by $0.78. The business had revenue of $0.08 million during the quarter, compared to analyst estimates of $0.25 million. Amesite had a negative net margin of 850.55% and a negative return on equity of 162.26%.
Amesite Company Profile
Amesite Inc (NASDAQ:AMST) is a technology company that develops artificial intelligence-powered learning and training solutions. Its platform is designed to help educational institutions, businesses and government organizations create, deliver and manage online learning programs.
The company’s offerings support digital course delivery, learner engagement, content management and analytics. Amesite’s technology is intended to help organizations provide personalized and scalable education and workforce training, with applications that may include professional development, continuing education and other structured learning programs.
Amesite was founded in 2017 and is headquartered in Ann Arbor, Michigan.
See Also
- Five stocks we like better than Amesite
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
- Albertsons Is Betting on a Turnaround—But Will It Pay Off?
- Venezuela’s Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit
Receive News & Ratings for Amesite Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amesite and related companies with MarketBeat.com's FREE daily email newsletter.
